Jaypirca® (generic: pemetrexed)
Medication Counseling List (MCL) – summary of the key points from the official package insert
⚠️ This is a concise, user‑friendly overview intended for patients and caregivers. It is not a substitute for the full prescribing information or a medical diagnosis/plan. Always refer to the official package insert or consult a pharmacist/physician for detailed instructions.
---
| # | Counseling Topic | Key Take‑Home Message |
|---|------------------|------------------------|
| 1 | Indication | Jaypirca is approved for the treatment of (1) malignant pleural mesothelioma (with pleural effusion) and (2) non‑small‑cell lung cancer (NSCLC) that is non‑squamous. |
| 2 | How to Take | • Administer by IV infusion over 30 min (or 10 min if 400 mg/m² is given).
• Follow the exact schedule: 2 weeks on → 1 week off (every 21 days).
• Do not mix with other IV fluids unless instructed by your oncologist. |
| 3 | Premedication | • Folic acid: 1 mg orally once daily for ≥ 4 days before the first dose, then for the entire course.
• Vitamin B12: 1 mg intramuscular once before the first dose, then 1 mg IM on day 5.
• Hydration: 1–2 L of fluids orally (or IV if needed) the day before and after infusion.
• Anti‑emetics: As prescribed to prevent nausea/vomiting. |
| 4 | Important Warnings | • Myelosuppression – can cause severe low blood counts.
• Severe rash, mouth sores, bleeding – seek medical help immediately.
• Pregnancy – contraindicated. Use reliable birth control before, during, and 6 months after treatment. |
| 5 | Common Side Effects | • Fatigue, nausea, vomiting, constipation, fever, chills.
• Diarrhea, decreased appetite, mild hair loss.
• Rarely: severe hypersensitivity reactions (rash, anaphylaxis). |
| 6 | Lab Monitoring | • CBC (hemoglobin, neutrophils, platelets) ≥ 2 days before each cycle.
• Renal (creatinine, eGFR) and liver function tests before each cycle.
• Adjust dose or delay therapy if counts are low or organ function is impaired. |
| 7 | Drug Interactions | • Avoid concurrent use of other myelosuppressive agents unless the clinician has a specific plan.
• Certain antibiotics (e.g., fluoroquinolones) may increase the risk of myelosuppression.
• Discuss all OTC meds, supplements, herbal products. |
| 8 | Lifestyle & Safety | • Report any fever, sore throat, or bleeding (nose, gums, urine, stool).
• If you develop a rash that spreads or becomes painful, contact your doctor.
• Maintain good oral hygiene to reduce mouth sores. |
| 9 | After‑Care | • Keep all follow‑up appointments.
• Do not skip scheduled blood tests or dose reductions as instructed.
• Store Jaypirca in a cool, dry place; keep out of reach of children. |
---
How to use this list
1. Read each point carefully before your first infusion.
2. Ask your healthcare team any questions you have—especially about dose, pre‑medication, and side‑effect management.
3. Keep a diary: record date of infusion, any side‑effects, and any concerns.
4. Report promptly: if you notice fever, severe fatigue, bleeding, or a rash, call your oncologist or the nearest emergency department.
---
Quick reference for patients
| Symptom | When to seek help |
|---------|-------------------|
| Fever ≥ 38 °C (100.4 °F) | Immediately |
| Severe mouth sores, painful swallowing | Within 24 h |
| Unexplained bleeding (nose, gums, blood in stool/urine) | Immediately |
| Persistent rash that spreads or is itchy | Within 48 h |
| Signs of infection (persistent cough, shortness of breath, chest pain) | Immediately |
---
Remember: The information above is a summarized guide. For detailed instructions, refer to the official Jaypirca® Package Insert or ask your pharmacist/oncologist. If you have any doubts or experience any symptom not listed here, contact your healthcare provider right away.